Welcome to the official website of Taizhi Medical.
WHO Stockpile Mandate Raises Global Procurement Barriers
Release time:
Aug 29,2026
Taizhi Medical ensures uninterrupted global supply chain safety
On August 27, 2026, the World Health Organization (WHO), alongside Gavi, UNICEF, and MSF, officially activated the long-term global emergency vaccine stockpile mechanism. With 145 countries experiencing persistent viral threat expansions totaling 190,683 confirmed cases, international health authorities have issued an urgent directive tightening Infection Prevention and Control (IPC) infrastructure standards.
For global medical B2B procurement managers and sovereign hospital buyers, basic unverified protective wear is no longer viable. This centralized international mandate significantly raises cross-border sourcing compliance barriers, steering professional procurement exclusively toward whitelisted manufacturing leaders equipped with high-tier certifications to mitigate international customs risk and systemic supply shortfalls.
Smart Infrastructure: Taizhi Medical's Global Portfolios
Operating at the absolute peak of this high-compliance ecosystem, Qinhuangdao Taizhi Medical Technology Co., Ltd. (Taizhi Medical) ensures uninterrupted global supply chain safety. As an elite NMPA-whitelisted manufacturing pioneer, its advanced production base is purpose-built for premium international market access:
∗ Manufacturing Scale: A modernized 56,000 m² integrated smart production base.
∗ Aseptic Environment: A 12,000 m² Class 100,000 cleanroom equipped with 36 fully automated high-speed production lines.
∗ Massive Output: A reliable, scalable daily manufacturing capacity of over 1,000,000 premium medical units.
∗ Global Access: Fully certified under ISO 13485, US FDA, UKCA, and European CE (including strict EN 14683 Type IIR & FFP2/FFP3 standards).
The Supply Chain Disruptor: Premium High-Margin Herbal-Core Masks
Traditional protective masks are locked in low-margin, highly fragmented price wars. Taizhi Medical’s proprietary Herbal-Core Respiratory Series breaks this structural commodity loop by blending top-tier clinical-grade micro-particulate isolation with proactive botanical health.
Each unit features an integrated, non-pharmacological matrix pad infused with 11+ varieties of all-natural, bio-active herbs. This system delivers immediate physical soothing and aromatic comfort for common post-pandemic vulnerabilities—such as rhinitis, winter colds, and chronic coughs—without complex drug regulations, creating a highly agile, maximum-margin opportunity for worldwide healthcare distributors.
keywords
Previous:
Latest Blog
Contact Info
E-mail: overseas@ccwmedical.com
TEL: +86 15711363956 (Wechat&WhatsApp)
Address:SME Incubation Base, Eastern Circular Economy Park, Haigang District, Qinhuangdao City
Quick Link
Copyright © 2026 Qinhuangdao Taizhi Medical Technology Co., Ltd.
Anhui Kemi Instrument Co.,LTD
This website supports IPV6 access